Clinical Research Associate with a strong focus on identifying inflammatory genes and molecular biomarkers that drive disease severity and treatment response. Her work sits at the intersection of genomics, clinical research, and data science. She leads data analysis and research operations, where she manage, clean, and interpret large-scale genomic and clinical datasets to generate insights that support evidence-based decision-making.
Particularly interested in understanding the biological drivers of aggressive breast cancer subtypes. Inflammatory biomarkers play a critical role in tumour progression, metastasis, and therapeutic outcomes, and my research explores how these markers can be leveraged to improve patient stratification and precision treatment.
In her dual role as a Clinical Research Associate at Oncopadi Tech and a Data Analyst at Pearl, she contribute to advancing breast cancer research and improving clinical workflows. Her current work focuses on integrating multi-omics data, clinical variables, and artificial intelligence to strengthen translational breast cancer research and close gaps in precision oncology across Africa.